Cell type injected | Bone turnover | Neovascularization | Inflammatory cytokines | Extracellular matrix remodeling | ||||
---|---|---|---|---|---|---|---|---|
ALP (%) | OPN (%) | aSMA (%) | VEGF (%) | IL-6 (%) | MCP-1 (%) | Col-1 (%) | MMP3 (%) | |
Cortical and trabecular bone (endosteal niche) | ||||||||
EO + 231 | 29 | 47 | 71 | 33 | 2 | 1 | 55 | 44 (away from BC) |
OB + 231 | 0 | 80 | 63 | 25 | 55 | 16 | 64 | 41 (away from BC) |
231 alone | 0 | 39 | 50 | 0 | 37 | 0 | 55 | 17 (close to BC) |
Bone marrow (hematopoietic niche) | ||||||||
EO + 231 | 15 | 45 | 54 | 23 | 27 | 35 | 0 | 12 |
OB + 231 | 27 | 0 | 57 | 41 | 40 | 39 | 0 | 25 |
231 alone | 13.5 | 17 | 42 | 0 | 27 | 32 | 37 | 33 |
Tumor itself | ||||||||
EO + 231 | 0 | 35 | 28 | 29 | 17 | 0 | 24 | 17 |
OB + 231 | 0 | 0 | 15 | 13 | 0 | 5 | 24 | 5 |
231 alone | 12 | 15 | 19 | 17 | 0 | 31 | 23.5 | 33 |